Recent News
Arcturus Retains The Chase Group to Expand Vaccine Development Programs
As part of its growth strategy, Arcturus Therapeutics has partnered with The Chase Group to build and expand their vaccines development team. Founded in 2013… Continue Reading →The Chase Group Secures SVP, Regulatory for Atsena Therapeutics in Impressive Timeframe
After a comprehensive executive search that was completed in less than six weeks, The Chase Group is pleased to announce the placement of Dr. Molly… Continue Reading →
The Chase Group Retained to Identify Vice President, Manufacturing/Supply Chain
Ventria Bioscience has partnered with The Chase Group to continue building its leadership team. The company’s technology is time-proven, with more than ten years of… Continue Reading →
Successful Collaboration Results in VP Finance Placement at Ionis
The Chase Group (TCG) is pleased to announce the successful recruitment of James Haney as the Vice President of Finance at Ionis Pharmaceuticals. Haney joins… Continue Reading →
Alexza Pharmaceuticals Partnership Continues with Quality Assurance Leadership Search
Alexza Pharmaceuticals continues to partner with The Chase Group to secure a Senior Director/Head, Quality Assurance. The Chase Group is currently seeking quality assurance professionals… Continue Reading →Atsena Therapeutics Retains The Chase Group to Identify Head of Regulatory
Atsena Therapeutics has retained The Chase Group to identify a Head of Regulatory. Chase is proud to partner with this clinical-stage ocular gene therapy company… Continue Reading →Ventria Continues Partnership With The Chase Group to Find Agronomy Operations Leader
Ventria Bioscience has partnered once again with The Chase Group to continue building their leadership team as they develop and commercialize innovative medicines with an… Continue Reading →Ventria Bioscience Cuts to The Chase!
Ventria Bioscience is embarking on a path of accelerated growth as they work to double their capacity for multiple products this year. As part of… Continue Reading →